ORBIMED ADVISORS LLC Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$6.2B
Holdings
141
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (141 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | BLUBELLUS HEALTH INC NEW | 1,454,800 | $10.1B | 163.25% | |
| 102 | XBISPDR SER TR | 111,800 | $10.0B | 162.94% | |
| 103 | AVTEAEROVATE THERAPEUTICS INC | 509,949 | $9.3B | 151.56% | |
| 104 | GLTOUSDGALECTO INC | 4,090,937 | $9.0B | 145.93% | |
| 105 | CYBNEURCYBIN INC | 10,524,300 | $8.6B | 139.41% | |
| 106 | —IMARA INC | 4,386,568 | $8.2B | 133.72% | |
| 107 | —GEMINI THERAPEUTICS INC | 5,826,224 | $8.1B | 131.31% | |
| 108 | GRPHGRAPHITE BIO INC | 1,565,812 | $8.0B | 129.49% | |
| 109 | RAPTEURRAPT THERAPEUTICS INC | 361,300 | $7.9B | 128.83% | |
| 110 | —SONENDO INC | 1,968,180 | $7.9B | 127.97% | |
| 111 | CGEMCULLINAN ONCOLOGY INC | 670,787 | $7.0B | 113.88% | |
| 112 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,956,124 | $6.8B | 110.24% | |
| 113 | —MAGENTA THERAPEUTICS INC | 2,250,953 | $6.5B | 105.85% | |
| 114 | —9 METERS BIOPHARMA INC | 10,275,887 | $6.2B | 99.85% | |
| 115 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 6,000,000 | $6.1B | 98.68% | |
| 116 | BDQMALBIREO PHARMA INC | 194,000 | $5.8B | 93.83% | |
| 117 | —LOGICBIO THERAPEUTICS INC | 8,466,783 | $5.8B | 93.36% | |
| 118 | CTMXCYTOMX THERAPEUTICS INC | 2,124,975 | $5.7B | 92.00% | |
| 119 | PHGEBIOMX INC | 2,813,489 | $5.4B | 88.05% | |
| 120 | —ONCOCYTE CORP | 3,493,800 | $5.2B | 84.41% | |
| 121 | —GRAYBUG VISION INC | 4,163,347 | $5.1B | 83.04% | |
| 122 | VORVOR BIOPHARMA INC | 833,333 | $5.0B | 81.61% | |
| 123 | 698ACHILLES THERAPEUTICS PLC | 1,584,845 | $4.7B | 75.54% | |
| 124 | TARAPROTARA THERAPEUTICS INC | 830,641 | $4.2B | 68.83% | |
| 125 | IMCRIMMUNOCORE HLDGS PLC | 128,100 | $3.8B | 62.10% | |
| 126 | AFIBACUTUS MED INC | 2,648,386 | $3.7B | 59.69% | |
| 127 | SRPTSAREPTA THERAPEUTICS INC | 39,100 | $3.1B | 49.52% | |
| 128 | VIGLVIGIL NEUROSCIENCE INC | 411,191 | $2.9B | 46.88% | |
| 129 | —TALARIS THERAPEUTICS INC | 247,240 | $2.4B | 39.45% | |
| 130 | ASNSUSDX4 PHARMACEUTICALS INC | 1,373,849 | $2.4B | 38.98% | |
| 131 | SGHTSIGHT SCIENCES INC | 200,000 | $2.3B | 37.49% | |
| 132 | NBPI MAB | 111,120 | $1.8B | 29.27% | |
| 133 | EXAIEUREXSCIENTIA PLC | 125,000 | $1.8B | 29.19% | |
| 134 | —ASLAN PHARMACEUTICALS LTD | 1,941,219 | $1.7B | 28.33% | |
| 135 | —APTINYX INC | 538,500 | $1.2B | 19.81% | |
| 136 | CABACABALETTA BIO INC | 577,509 | $1.2B | 19.00% | |
| 137 | —FIELD TRIP HEALTH LTD | 576,930 | $762.0M | 12.36% | |
| 138 | —LONGBOARD PHARMACEUTICALS IN | 113,500 | $606.0M | 9.83% | |
| 139 | MIRMMIRUM PHARMACEUTICALS INC | 27,000 | $595.0M | 9.65% | |
| 140 | PYXSPYXIS ONCOLOGY INC | 143,640 | $580.0M | 9.40% | |
| 141 | —LANDOS BIOPHARMA INC | 283,217 | $418.0M | 6.78% | |
| 142 | —OWLET INC | 220,704 | $170.0M | 2.76% |
PreviousPage 2 of 2